{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:32:06Z","timestamp":1793385126717,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032291","name":"Demarest Lloyd Jr Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jad.2026.122277","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:37:03Z","timestamp":1784216223000},"page":"122277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A randomized trial of omega-3 fatty acids plus inositol versus N-acetylcysteine for the treatment of depression and mania in emotionally dysregulated youth age 5\u201317 with and without autism traits"],"prefix":"10.1016","volume":"414","author":[{"given":"Janet","family":"Wozniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Iorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"DiSalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagar","family":"Kandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atilla Tolga","family":"Ceranoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Faraone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jad.2026.122277_bb0005","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/acm.2004.10.1033","article-title":"Pilot study of a moderate dose multivitamin\/mineral supplement for children with autistic spectrum disorder","volume":"10","author":"Adams","year":"2004","journal-title":"J. Altern. Complement. Med. (New York, N.Y.)"},{"key":"10.1016\/j.jad.2026.122277_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-11-111","article-title":"Effect of a vitamin\/mineral supplement on children and adults with autism","volume":"11","author":"Adams","year":"2011","journal-title":"BMC Pediatr."},{"issue":"3","key":"10.1016\/j.jad.2026.122277_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/nu10030369","article-title":"Comprehensive nutritional and dietary intervention for autism spectrum disorder-a randomized, controlled 12-month trial","volume":"10","author":"Adams","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jad.2026.122277_bb0020","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12887-022-03628-0","article-title":"Vitamin\/mineral\/micronutrient supplement for autism spectrum disorders: a research survey","volume":"22","author":"Adams","year":"2022","journal-title":"BMC Pediatr."},{"issue":"9","key":"10.1016\/j.jad.2026.122277_bb0025","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2006.02.025","article-title":"Latent class analysis shows strong heritability of the CBCL-juvenile bipolar phenotype","volume":"60","author":"Althoff","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2026.122277_bb0030","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1469-7610.2009.02089.x","article-title":"Child Behavior Checklist Juvenile Bipolar Disorder (CBCL-JBD) and CBCL Posttraumatic Stress Problems (CBCL-PTSP) scales are measures of a single dysregulatory syndrome","volume":"50","author":"Ayer","year":"2009","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2026.122277_bb0035","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/ajp.146.10.1251","article-title":"Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium","volume":"146","author":"Baraban","year":"1989","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2026.122277_bb0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/DBP.0b013e3181e56ddd","article-title":"Child behavior checklist clinical scales discriminate referred youth with autism spectrum disorder: a preliminary study","volume":"31","author":"Biederman","year":"2010","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"3","key":"10.1016\/j.jad.2026.122277_bb0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/DBP.0b013e3182475267","article-title":"Severity of the aggression\/anxiety-depression\/attention child behavior checklist profile discriminates between different levels of deficits in emotional regulation in youth with attention-deficit hyperactivity disorder","volume":"33","author":"Biederman","year":"2012","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.jad.2026.122277_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/NDT.S29670","article-title":"Longitudinal course of deficient emotional self-regulation CBCL profile in youth with ADHD: prospective controlled study","volume":"8","author":"Biederman","year":"2012","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.jad.2026.122277_bb0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1017\/S0033291711001644","article-title":"Deficient emotional self-regulation and pediatric attention deficit hyperactivity disorder: a family risk analysis","volume":"42","author":"Biederman","year":"2012","journal-title":"Psychol. Med."},{"issue":"1\u20133","key":"10.1016\/j.jad.2026.122277_bb0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jad.2012.10.028","article-title":"Personal and familial correlates of bipolar (BP)-I disorder in children with a diagnosis of BP-I disorder with a positive child behavior checklist (CBCL)-severe dysregulation profile: a controlled study","volume":"147","author":"Biederman","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.jad.2026.122277_bb0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/1087054715596576","article-title":"A familial risk analysis of emotional dysregulation: a controlled study","volume":"22","author":"Biederman","year":"2018","journal-title":"J. Atten. Disord."},{"issue":"9","key":"10.1016\/j.jad.2026.122277_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094824","article-title":"Nutraceuticals in psychiatric disorders: a systematic review","volume":"25","author":"Bozzatello","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jad.2026.122277_bb0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/pgs-2016-0167","article-title":"Pharmacogenomics of autism spectrum disorder","volume":"18","author":"Brown","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jad.2026.122277_bb2075","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"9","key":"10.1016\/j.jad.2026.122277_bb0080","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1089\/cap.2019.0036","article-title":"Mineral-vitamin treatment associated with remission in attention-deficit\/hyperactivity disorder symptoms and related problems: 1-year naturalistic outcomes of a 10-week randomized placebo-controlled trial","volume":"29","author":"Darling","year":"2019","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.jad.2026.122277_bb0085","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1017\/S1368980021000665","article-title":"Dietary supplements in the USA: problematic trends","volume":"24","author":"Denham","year":"2021","journal-title":"Public Health Nutr."},{"issue":"10","key":"10.1016\/j.jad.2026.122277_bb0090","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1087054712462884","article-title":"Deficient emotional self-regulation in ADHD assessed using a unique profile of the child behavior checklist (CBCL): replication in an Italian study","volume":"19","author":"Donfrancesco","year":"2015","journal-title":"J. Atten. Disord."},{"issue":"10, Supplement","key":"10.1016\/j.jad.2026.122277_bb0095","first-page":"S271","article-title":"5.50 examining the prevalence and clinical correlates of comorbid ASD and MDD in intellectually intact youth: a comparative study","volume":"63","author":"Ghumman","year":"2024","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.122277_bb0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1054\/plef.1999.0037","article-title":"Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes","volume":"60","author":"Horrobin","year":"1999","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"3","key":"10.1016\/j.jad.2026.122277_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","article-title":"The membrane hypothesis of schizophrenia","volume":"13","author":"Horrobin","year":"1994","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.jad.2026.122277_bb0110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.biopsych.2005.03.024","article-title":"Prevalence and genetic architecture of Child Behavior Checklist-juvenile bipolar disorder","volume":"58","author":"Hudziak","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2026.122277_bb0115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaac.2021.07.005","article-title":"Micronutrients for attention-deficit\/hyperactivity disorder in youths: a placebo-controlled randomized clinical trial","volume":"61","author":"Johnstone","year":"2022","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2026.122277_bb0120","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10803-010-0996-9","article-title":"The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population","volume":"40","author":"Joshi","year":"2010","journal-title":"J. Autism Dev. Disord."},{"issue":"1","key":"10.1016\/j.jad.2026.122277_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1755-5949.2010.00219.x","article-title":"Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder","volume":"18","author":"Joshi","year":"2012","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.jad.2026.122277_bb0130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4088\/JCP.12m07392","article-title":"Examining the comorbidity of bipolar disorder and autism spectrum disorders: a large controlled analysis of phenotypic and familial correlates in a referred population of youth with bipolar I disorder with and without autism spectrum disorders","volume":"74","author":"Joshi","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122277_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/s10803-018-3542-9","article-title":"High risk for severe emotional dysregulation in psychiatrically referred youth with autism spectrum disorder: a controlled study","author":"Joshi","year":"2018","journal-title":"J. Autism Dev. Disord."},{"issue":"10","key":"10.1016\/j.jad.2026.122277_bb2135","doi-asserted-by":"crossref","first-page":"e2534927","DOI":"10.1001\/jamanetworkopen.2025.34927","article-title":"Memantine to treat social impairment in youths with autism spectrum disorder: A randomized clinical trial","volume":"8","author":"Joshi","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"11","key":"10.1016\/j.jad.2026.122277_bb0140","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/02698811251344683","article-title":"Adverse event monitoring, assessment, and reporting in nutraceutical and phytoceutical trials for pediatric neuropsychiatric conditions: A systematic review","volume":"39","author":"Lodewyk","year":"2025","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2026.122277_bb0145","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1516-44462011000400011","article-title":"N-acetylcysteine for major depressive episodes in bipolar disorder. Randomized Controlled Trial","volume":"33","author":"Magalhaes","year":"2011","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"5","key":"10.1016\/j.jad.2026.122277_bb0150","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s10803-018-3860-y","article-title":"A randomised-controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of core symptoms of autism spectrum disorder in children","volume":"49","author":"Mazahery","year":"2019","journal-title":"J. Autism Dev. Disord."},{"issue":"3","key":"10.1016\/j.jad.2026.122277_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/nu12030661","article-title":"Inflammation (IL-1\u03b2) modifies the effect of vitamin D and omega-3 long chain polyunsaturated fatty acids on core symptoms of autism spectrum disorder-an exploratory pilot study","volume":"12","author":"Mazahery","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.jad.2026.122277_bb0160","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0006-3223(03)00234-8","article-title":"A preliminary meta-analysis of the child behavior checklist in pediatric bipolar disorder","volume":"53","author":"Mick","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2026.122277_bb0165","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jaac.2011.05.001","article-title":"Genome-wide association study of the child behavior checklist dysregulation profile","volume":"50","author":"Mick","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2026.122277_bb0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(97)00206-0","article-title":"Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients","volume":"43","author":"Peet","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2026.122277_bb0175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/15374416.2019.1697929","article-title":"Latent class analysis of the CBCL dysregulation profile for 6- to 16-year-olds in 29 societies","volume":"50","author":"Rescorla","year":"2021","journal-title":"J. Clin. Child Adolesc. Psychol."},{"issue":"3","key":"10.1016\/j.jad.2026.122277_bb0180","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jcpp.12817","article-title":"Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial","volume":"59","author":"Rucklidge","year":"2018","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2026.122277_bb0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3810\/pgm.2011.09.2459","article-title":"Toward defining deficient emotional self-regulation in children with attention-deficit\/hyperactivity disorder using the Child Behavior Checklist: a controlled study","volume":"123","author":"Spencer","year":"2011","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jad.2026.122277_bb0190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega 3 fatty acids in bipolar disorder","volume":"56","author":"Stoll","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2026.122277_bb0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S0007114515004390","article-title":"A randomised double-blind placebo-controlled trial investigating the behavioural effects of vitamin, mineral and n-3 fatty acid supplementation in typically developing adolescent schoolchildren","volume":"115","author":"Tammam","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.jad.2026.122277_bb0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jad.2014.04.021","article-title":"Further evidence that severe scores in the aggression\/anxiety-depression\/attention subscales of child behavior checklist (severe dysregulation profile) can screen for bipolar disorder symptomatology: a conditional probability analysis","volume":"165","author":"Uchida","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122277_bb0205","article-title":"Genetic overlap between attention-deficit\/hyperactivity disorder and bipolar disorder: evidence from genome-wide association study meta-analysis","author":"van Hulzen","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2026.122277_bb0210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/cap.2017.0080","article-title":"Pilot data supporting omega-3 fatty acids supplementation in medicated children with attention-deficit\/hyperactivity disorder and deficits in emotional self-regulation","volume":"27","author":"Wilens","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122277_bb0215","series-title":"Open-label Study of N-Acetylcysteine in Children and Adolescents with Bipolar Spectrum Disorders: An Interim Analysis. Poster Presented at: American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting","author":"Wolenski","year":"2017"},{"issue":"10, Supplement","key":"10.1016\/j.jad.2026.122277_bb0220","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1016\/j.jaac.2025.07.695","article-title":"4.7 integrating the quality of psychopharmacological evidence into treatment with nutraceuticals","volume":"64","author":"Wozniak","year":"2025","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"6\u20137","key":"10.1016\/j.jad.2026.122277_bb0225","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.euroneuro.2006.11.006","article-title":"Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial","volume":"17","author":"Wozniak","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2026.122277_bb0230","first-page":"62","article-title":"A magnetic resonance spectroscopy study of the anterior cingulate cortex in youth with emotional dysregulation","volume":"49","author":"Wozniak","year":"2012","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"issue":"11","key":"10.1016\/j.jad.2026.122277_bb0235","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4088\/JCP.14m09267","article-title":"A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study","volume":"76","author":"Wozniak","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2026.122277_bb0240","article-title":"Correction: a randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study. Published erratum","volume":"77","author":"Wozniak","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.122277_bb0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.64719\/pb.4449","article-title":"A randomized, double-blind, controlled clinical trial of omega-3 fatty acids and inositol as monotherapies and in combination for the treatment of pediatric bipolar Spectrum disorder in children age 5-12","volume":"52","author":"Wozniak","year":"2022","journal-title":"Psychopharmacol. Bull."},{"issue":"1","key":"10.1016\/j.jad.2026.122277_bb0250","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12888-022-03943-x","article-title":"Findings from a pilot open-label trial of N-acetylcysteine for the treatment of pediatric mania and hypomania","volume":"22","author":"Wozniak","year":"2022","journal-title":"BMC Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726011304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726011304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:50:51Z","timestamp":1793382651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726011304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":52,"alternative-id":["S0165032726011304"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122277","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized trial of omega-3 fatty acids plus inositol versus N-acetylcysteine for the treatment of depression and mania in emotionally dysregulated youth age 5\u201317 with and without autism traits","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122277"}}